UBS Group »

60 Degrees Pharmaceuticals I shares owned by UBS Group

Quarter-by-quarter ownership of 60 Degrees Pharmaceuticals I (SXTP) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in 60 Degrees Pharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including 60 Degrees Pharmaceuticals I held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 60 Degrees Pharmaceuticals I by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2k 1.5k 1.48
2025-06-30 $32 14 2.36
2025-03-31 $30k 16k 1.84

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding 60 Degrees Pharmaceuticals I

DRW Holdings
Geode Capital Management
Tower Research Capital
UBS Group
Advisor Group Holdings

View all funds holding 60 Degrees Pharmaceuticals I